A study found that prescriptions for GIP/GLP-1 RA drugs may reduce opioid overdose and alcohol intoxication rates in patients with OUD and AUD, offering potential new treatments for addiction.

In a huge new statistical analysis, researchers have found more evidence than ever that drugs like Ozempic can help curb alcohol and opioid addiction. Published in the journal Addiction, this new study saw researchers from Loyola University Chicago sift through more than 1.

Research published in the journal Addiction indicates that GLP-1 drugs like Ozempic may play a crucial role in reducing substance abuse.

The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.

Weight-loss drugs such as Ozempic, made by Denmark’s Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer greater benefits than just weight and diabetes management.

Drugs​ like Mounjaro and Ozempic, which many use for weight loss,​​ may also help patients suffering from addiction, according to a new study.

Drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by up to 50%, a study found, adding to mounting evidence that the drugs yield health benefits beyond diabetes and weight loss.

Weight loss medications such as Ozempic may be able to cut drug and alcohol misuse in half, according to a new study from the scientific journal Addiction. The research, published Thursday, found that people who take Ozempic or similar drugs — those used for weight loss or treating Type 2 diabetes — were 40

Researchers analyzed 1.3 million health records and found Ozempic, Mounjaro could lower rates of drug and alcohol overdoses.

A new study has found that drugs like Ozempic, which were originally designed for people with type 2 diabetes before gaining popularity for weight loss, could treat alcohol addiction too. Around 2.6 million deaths per year are attributable to alcohol consumption,